NoBACZ
NoBACZ Healthcare is a University of Cambridge spinout developing patented antibiotic-free hydrophobic gel barrier products for wound and navel care in livestock and horses, sold through veterinary practices, agricultural merchants, and exclusive international distributors across Europe, the US, and Oceania.
- Company typePrivate
- Founded2018
- HeadquartersCambridge, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What NoBACZ does
NoBACZ Healthcare is a University of Cambridge spinout founded in 2018 by Dr Jonathan Powell and Dr Nuno Faria following research in the Department of Veterinary Medicine into how the body builds and utilises mineral structures. The company has developed a patented hydrophobic gel barrier technology that combines natural resin or polymer with mineral salts (zinc or copper) in an ethanol base to form rapid-setting, waterproof, antibiotic-free physical barriers. The technology is designed to address wound and lesion management challenges in farm environments where traditional bandages and antibiotic sprays fail due to contamination from slurry, water, and mud. Products set within approximately 60 seconds, are pressure-proof within an hour, provide 1-3 days of protection, and biodegrade naturally without requiring removal.
The company's product portfolio includes NoBACZ Bovine (cattle wound protection, £45.00 per 138g cartridge), NoBACZ Navel (neonatal navel care sold as UMBIREZ internationally, £31.25), Ambugreen (zinc-salt multi-species livestock gel, £39.95 per 110g tube), and Cuvestrequin (copper-salt equine-specific wound gel). The products serve livestock producers, equine veterinarians, and veterinary practices across cattle, sheep, and pig segments. Efficacy is supported by the largest-ever navel protection study (6,840 lambs) demonstrating a 21% reduction in mortality versus iodine, an 18-lamb-per-1,000 survival advantage, and 360g heavier weights at eight weeks, plus a 98% day-7 healing rate in disbudding trials.
NoBACZ operates a B2B distribution-led model selling through UK agricultural merchants (MWI, Vet-Way, Wynnstay, Carrs Billington), veterinary practices, and exclusive country distributors across Ireland, Benelux, Switzerland, Liechtenstein, Cyprus, Türkiye, the Baltic States, Romania, the United States, and New Zealand. Go-to-market combines field sales at industry conferences (BCVA Congress, High Plains Dairy Conference), AMTRA-accredited SQP training through VBMS, content marketing, and direct e-commerce. Cumulative funding totals approximately £8.8 million across rounds in 2020, 2023, and October 2025, with the most recent £4.8m round led by The Yield Lab. The company operates from Cambridge, UK with 1-10 employees.
NoBACZ firmographics
Firmographics- Name
- NoBACZ
- Legal name
- NoBACZ Healthcare Ltd.
- Website
- https://nobacz.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- NoBACZ Healthcare is a University of Cambridge spinout developing patented antibiotic-free hydrophobic gel barrier products for wound and navel care in livestock and horses, sold through veterinary practices, agricultural merchants, and exclusive international distributors across Europe, the US, and Oceania.
- Ownership category
- akta.pro rank
NoBACZ industry classification
Industry- Product category
- Veterinary Animal Health and Wound Care
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)
- akta.pro secondary industry
- Pharmacy, Biologics & Veterinary Supply Dispensing (Farm Animal) (AFACADAM)
Keywords
Where NoBACZ is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
NoBACZ business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Product Sales: NoBACZ generates revenue through sale of antibiotic-free wound management products including NoBACZ Bovine, NoBACZ Navel, Ambugreen, and Cuvestrequin. Products are sold in various pack sizes (tubes, cartridges, tins) through agricultural merchants, veterinary practices, and direct e-commerce. International products sold under UMBIREZ brand.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | NoBACZ Bovine - 138g gel cartridge for cattle wound management |
| Unit Pricing | Pay-as-you-go | NoBACZ Navel - Liquid navel protection solution |
| Unit Pricing | Pay-as-you-go | Ambugreen - 110g tube gel barrier for livestock |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels7 records
NoBACZ product offering
Product offeringCore offering
NoBACZ Healthcare manufactures and sells patented antibiotic-free liquid bandage products for veterinary use, applying a hydrophobic gel barrier technology that combines natural resin or polymer with mineral salts (zinc or copper) in an ethanol base. The products set within approximately 60 seconds to form waterproof physical barriers that block microbes and repel water, then biodegrade naturally on the animal. The core product line includes NoBACZ Bovine (cattle wound management), NoBACZ Navel/UMBIREZ (neonatal lamb and calf navel protection), Ambugreen (multi-species livestock barrier), and Cuvestrequin (equine wound care), sold through agricultural merchants, veterinary practices, and exclusive international distributors.
Product overview
NoBACZ Healthcare offers a portfolio of physical barrier wound care products based on patented hydrophobic gel barrier technology. The core product line includes NoBACZ Bovine (cattle wound/barrier gel), NoBACZ Navel (neonatal navel protection), and Ambugreen (multi-species livestock barrier gel). An equine-specific product, Cuvestrequin, serves the horse market. Internationally, the navel product is branded as UMBIREZ. All products use natural resin or polymer combined with metal salts (zinc or copper) in an ethanol base to create instant, waterproof, antibiotic-free barriers that biodegrade naturally. The technology originated from University of Cambridge research into mineral-polymer compositions.
Differentiator
Problem solved
Functional benefit
Brands
- Ambugreen: Antibiotic-free waterproof gel barrier for livestock providing physical and microbial protection for 1-3 days. Suitable for all livestock including copper-sensitive sheep breeds.
- NoBACZ Bovine
- NoBACZ Navel
- Cuvestrequin
Products and services
- NoBACZ Bovine First topical protection product offering a physical protective coating combined with a durable microbial barrier for cattle. 138g gel cartridge that forms a hydrophobic waterproof barrier, sets in approximately one minute, and is pressure-proof within approximately one hour. Biodegradable and self-degrading with no waste. Priced at £45.00 per cartridge providing approximately 48 applications.
- NoBACZ Navel First navel product combining physical protective coating with trusted cleansing and rapid desiccation. Contains natural polymer and metal salts in an ethanol base. Proven in the largest-ever navel protection study (6,840 lambs) to deliver a 21% reduction in lamb mortality versus iodine. Available in 500ml bottle and 1 litre tin at £31.25 with approximately 200 applications per litre tin.
- Ambugreen Waterproof, antibiotic-free gel barrier for livestock wound management with 110g recyclable aluminium tube. Combines natural resin with zinc salts providing both physical and microbial protection for 1 to 3 days. Suitable for all livestock including copper-sensitive sheep breeds. Quick-drying, waterproof, biodegradable with fly protection. Priced at £39.95 per tube.
- Cuvestrequin Pioneering wound care product for horses developed specifically for equine veterinary professionals. Features natural polymer combined with copper salts in an ethanol base providing a waterproof barrier. 90g tube, completely biodegradable, with fly protection and curated for equine skin. Used for proud flesh management, difficult-to-bandage sites, surgical wounds, and general lesion protection.
- UMBIREZ International brand name for NoBACZ Navel sold outside the UK market. Same patented formulation providing cleansing, rapid drying, and waterproof physical barrier for neonatal navel protection in lambs and calves. Sold in the United States, New Zealand, and other international markets via exclusive distribution partners.
Quantifiable outcome
- 21% reduction in lamb mortality versus iodine in 6,840 lamb study
- +5 more outcomes
Companies that use NoBACZ
Customer profileNamed customers12 records
Segments3 records
Ideal customer profiles3 records
NoBACZ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NoBACZ partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and supporting.
- Nupsala-EUcoreExclusive distributor for NoBACZ livestock and equine products in Romania starting January 2026. Rapidly growing leader in Romania's veterinary sector with specialist portfolio in orthopaedics, regenerative medicine, farm health, and equine care.
- GLA PharmacoreExclusive distributor for NoBACZ livestock and equine products in New Zealand. 100% NZ owned and operated, experienced importer and distributor with significant veterinary experience and focus on teaching and training.
- Gökçay GroupcoreExclusive distributor for NoBACZ livestock products in Türkiye. Family-run company bringing innovative products to Turkish agricultural sector with strong small ruminant focus.
- Virtual Business Management Solutions (VBMS)corePartnership to deliver AMTRA-accredited training courses for SQPs. Three courses launched covering navel hygiene, orf management, and neonatal calf health. Courses provide CPD points for animal health professionals.
- Dimedium GroupcoreExclusive distributor for NoBACZ livestock products in Latvia, Lithuania, and Estonia. Distinguished name in Baltic agriculture and animal health sector with exclusive agreements with key global manufacturers.
- Premier1SuppliescoreInitial US stockist for UMBIREZ navel product. Leading US agricultural supplier serving livestock producers.
- Dr E. Graeub AGcoreExclusive distributor for NoBACZ livestock and equine products in Switzerland and Liechtenstein. Long-standing name in animal health sector with exclusive agreements with key global manufacturers.
- FarmVetCare C.P. LtdcoreExclusive distributor for NoBACZ livestock and equine products in Cyprus. Offers clinical veterinary services to farmers plus distribution, supporting and educating other vets in the region.
- Interchem/PharvetcoreExclusive distributor for NoBACZ livestock products (NoBACZ Navel, Ambugreen) and Cuvestrequin in Ireland and Northern Ireland. Leading distributor of animal health products with history of introducing innovative products.
- KernFarm BVcoreExclusive distributor for NoBACZ products in Belgium, Luxembourg, and Netherlands.
- American Sale and Ag SupplycoreMajor expansion of US distribution network for UMBIREZ and Ambugreen products, increasing national availability across United States.
- NupsalacoreExclusive distributor for Cuvestrequin in Great Britain. Leading distributor of advanced veterinary solutions with great relationships within practice and extensive portfolio of innovative products.
- High Plains Dairy ConferencesupportingGold sponsor of 2026 High Plains Dairy Conference in Amarillo, Texas. Conference brings together dairy producers, veterinarians, nutritionists, and industry leaders to explore latest research and technologies.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
NoBACZ competitors and assessment
Company assessmentBroad incumbents
- Dechra Pharmaceuticals: Specialty animal-health pharmaceutical company with a strong portfolio in veterinary wound care, dermatology and livestock therapeutics. Directly comparable as a competitor in the veterinary wound/lesion management space where NoBACZ is positioning its products.
- Vetoquinol: Global animal-health company selling pharmaceuticals and topical products for livestock and companion animals. Comparable as a broad incumbent offering wound-care and lesion-management products to overlapping veterinary and livestock-producer customers.
- Virbac: International animal-health company with a meaningful livestock and wound-care portfolio. Directly comparable to NoBACZ as a competing supplier of topical veterinary wound and lesion products to livestock producers and vets.
- Zoetis: Largest global animal-health company offering a full range of livestock pharmaceuticals, vaccines and topical products. Comparable as the dominant incumbent whose antibiotic and wound-care offerings NoBACZ is positioning against in the antimicrobial stewardship narrative.
- Elanco Animal Health: Major global animal-health company covering livestock and companion-animal therapeutics. Comparable as a broad incumbent whose livestock product lines compete with NoBACZ's wound/navel/lesion management solutions.
- Ceva Santé Animale: Global animal-health company with significant livestock and swine portfolios. Comparable as a broad incumbent competitor in livestock wound and lesion management, particularly relevant for NoBACZ's pig and sheep use cases.
- MSD Animal Health (Merck Animal Health): Global animal-health division of Merck offering livestock vaccines, parasiticides and topical products. Comparable as a broad incumbent whose livestock portfolio competes with NoBACZ in wound/navel management and benefits from the same antimicrobial stewardship tailwinds.
Direct peers
- Bimeda Animal Health: Specialty animal-health company focused on livestock pharmaceuticals and topicals with strong UK/Irish distribution. Closely comparable to NoBACZ as a competing supplier of topical wound, navel and lesion products sold through the same agricultural merchants and veterinary channels.
Emerging players
- Animedica / Animal Ethics: European veterinary specialty companies focused on innovative topical and wound-care solutions for livestock. Comparable to NoBACZ as emerging competitors pursuing evidence-based, antibiotic-free alternatives in the same veterinary wound-care niche.
Others
- Animal Health International (Covetrus): Major distributor of animal-health products including wound care and topicals to veterinary practices and livestock producers in the US. Comparable as a channel-side peer that competes for shelf space and distributor relationships with NoBACZ's US products UMBIREZ and Ambugreen.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
NoBACZ social profiles
Digital presenceNoBACZ financial estimates
Financial estimateRevenue estimate
Valuation estimate
NoBACZ leadership team
Management profileNumber of profiles
Profiles6 records
NoBACZ funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NoBACZ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NoBACZ
What does NoBACZ do?
NoBACZ Healthcare manufactures and sells patented antibiotic-free liquid bandage products for veterinary use, applying a hydrophobic gel barrier technology that combines natural resin or polymer with mineral salts (zinc or copper) in an ethanol base. The products set within approximately 60 seconds to form waterproof physical barriers that block microbes and repel water, then biodegrade naturally on the animal. The core product line includes NoBACZ Bovine (cattle wound management), NoBACZ Navel/UMBIREZ (neonatal lamb and calf navel protection), Ambugreen (multi-species livestock barrier), and Cuvestrequin (equine wound care), sold through agricultural merchants, veterinary practices, and exclusive international distributors.
Is NoBACZ a public or private company?
NoBACZ is a private company. It is classified as venture growth investor backed and is currently operating.
When was NoBACZ founded?
NoBACZ was founded in 2018. It employs 1 to 10 people.
Where is NoBACZ based?
NoBACZ is headquartered in Cambridge, United Kingdom, in the Europe region.
How does NoBACZ make money?
One revenue line is on record: product Sales.
Who are NoBACZ's main competitors?
Broad incumbents on record are Dechra Pharmaceuticals, Vetoquinol, Virbac, Zoetis, Elanco Animal Health, Ceva Santé Animale and MSD Animal Health (Merck Animal Health). Bimeda Animal Health is listed as a direct peer. Animedica / Animal Ethics is listed as an emerging player. Animal Health International (Covetrus) is listed as an others.
Does NoBACZ have an API?
No public API is recorded for NoBACZ.
What industry is NoBACZ in?
NoBACZ's product category is Veterinary Animal Health and Wound Care. Its primary akta.pro industry code is HLAMAFAF, Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers), with a secondary code of AFACADAM, Pharmacy, Biologics & Veterinary Supply Dispensing (Farm Animal). Its NAICS code is 3391 and its SIC code is 3841.